Cambridge Healthtech Institute’s Inaugural

Safety and Efficacy of Bispecific Antibodies

Achieving Potent and Effective Bispecifics for Targeted Therapeutic Benefit

14 November 2023

The role of bispecific antibodies for oncologic therapeutics and beyond continues to grow, bringing forth a focused effort on ensuring safety without compromising efficacy. At Cambridge Healthtech Institute’s Inaugural Safety and Efficacy of Bispecific Antibodies conference, challenges around toxicity and efficacy will be discussed in the context of emerging bispecifics and ADCs. Methods of mitigating toxicity while delivering potent bispecifics and ADCs will be explored, along with considerations for the clinical development lifecycle, from CMC strategy for clinical supply through to clinical safety and efficacy. Topics such as combination therapies and strategies for achieving better risk/benefit profiles to address currently unmet needs will be covered. The meeting seeks to complement topics in bispecific antibody discovery and engineering by honing in on clinical challenges and successes.

Coverage will include, but is not limited to:

Reviewing safety and efficacy profiles of emerging bispecifics
Addressing safety challenges and mitigating toxicity
Improving efficacy in the face of safety challenges
Deciding on the right combination therapy and bispecific construct
Considering the clinical development life cycle, from CMC to clinical
Assessing regulatory considerations for bispecifics and ADCs
Exploring innovations in CD3-based bispecifics and ADCs
Examining the impact of target selection on safety and efficacy

The deadline for priority consideration is 31 March 2023.

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

Opportunities for Participation:

To submit a podium presentation, please click here.
To become a sponsor, click here.
To present a poster, click here.
To sign up to attend, click here

For more details on the conference, please contact:

Iris Goldman
Associate Conference Producer
Cambridge Healthtech Institute
Phone: +1 781 247-1814
Email: igoldman@healthtech.com

Companies A-K
Jason Gerardi
Sr. Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-5452
Email: jgerardi@healthtech.com

Companies L-Z
Ashley Parsons
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-1340
Email: ashleyparsons@healthtech.com